October 2, 2019 / 7:33 AM / 2 months ago

Carl Zeiss Meditec ups guidance on stronger than expected sales

BERLIN, Oct 2 (Reuters) - Germany’s Carl Zeiss Meditec on Wednesday lifted its full-year guidance, saying it has significantly outstripped its revenue forecast for the current fiscal year and reached an adjusted growth rate of 11.9%.

“From today’s point of view, the company expects a strong increase in operating earnings (EBIT) and anticipates to significantly exceed the previous forecast of an EBIT margin between 15.0% to 17.5%”, the company said.

Carl Zeiss Meditec is due to report full-year results on Dec. 6.

Shares were up 2.6% in Frankfurt at 0725 GMT.

Reporting by Tassilo Hummel, editing by Riham Alkousaa

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below